Chemotherapy-handling practices of outpatient and office-based oncology nurses.
OBJECTIVE
To determine the current patterns of use of personal protective equipment among oncology nurses while handling antineoplastic chemotherapeutic agents in outpatient and office-based settings.


METHODS
Descriptive-correlational, mailed survey.


METHODS
National survey of oncology nurses.


METHODS
500 randomly selected members of the Oncology Nursing Society who identified their work settings as office, clinic, or outpatient private practice; 263 responded for an overall response rate of 53%.


METHODS
Mailed, self-report survey based on the current Occupational Safety and Health Administration's (OSHA's) guidelines for the handling of hazardous drugs.


METHODS
Chemotherapy-handling practices.


RESULTS
More than 94% of participants reported usually wearing gloves during chemotherapy handling; 55% reported using laboratory coats as protective garments. Usual use of face and respiratory protection was less than 6%. Chemotherapy was reported to be prepared in laminar air flow hoods in 99% of work settings. Only 46% of sites reportedly provided any type of medical monitoring.


CONCLUSIONS
Use and availability of personal protective equipment when handling chemotherapy have increased, but medical monitoring of exposed employees still is neither widely practiced nor consistent with OSHA guidelines.


CONCLUSIONS
Safety concerns and potential adverse health effects associated with the occupational handling of chemotherapeutic agents have been reported. Historically, nurses' adherence to chemotherapy-handling guidelines has been poor. Results suggest that adherence is increasing; however, research is lacking regarding nurses' level of knowledge of and specific barriers to safe handling of chemotherapy.
Martin
Susan
S
School of Nursing, Columbia University, New York, NY, USA. smartin7@optonline.net
Larson
Elaine
E
D000553:Ambulatory Care / Q000379:methods* / Q000592:standards; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004509:Education, Nursing, Continuing / Q000379:methods / Q000592:standards; D017575:Gloves, Protective / Q000706:statistics & numerical data / Q000600:supply & distribution; D019983:Guideline Adherence; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000451:nursing*; D016273:Occupational Exposure / Q000009:adverse effects / Q000517:prevention & control; D009818:Office Nursing / Q000592:standards*; D009859:Oncology Nursing / Q000193:education / Q000379:methods / Q000592:standards; D010045:Outpatients; D017410:Practice Guidelines as Topic / Q000592:standards; D011481:Protective Clothing / Q000706:statistics & numerical data / Q000600:supply & distribution; D011482:Protective Devices / Q000706:statistics & numerical data / Q000600:supply & distribution; D013041:Specialties, Nursing / Q000193:education / Q000379:methods / Q000592:standards; D011795:Surveys and Questionnaires
D000970:Antineoplastic Agents